RNA Interference Maintained in Stem Cells

Frontlines | RNA Interference Maintained in Stem Cells Short hairpin RNAs (shRNAs) offer a new way to silence genes, courtesy of RNA interference (RNAi). A study from Cold Spring Harbor Laboratory, home of the discovery of the RNAi enzyme dicer, indicates that these RNAs can be more than "off" switches. Different RNA hairpins corresponding to the same gene can squelch expression to different degrees, modulating a phenotype in a controlled way by tagging messenger RNAs for destruction. Gre

Written byRicki Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Short hairpin RNAs (shRNAs) offer a new way to silence genes, courtesy of RNA interference (RNAi). A study from Cold Spring Harbor Laboratory, home of the discovery of the RNAi enzyme dicer, indicates that these RNAs can be more than "off" switches. Different RNA hairpins corresponding to the same gene can squelch expression to different degrees, modulating a phenotype in a controlled way by tagging messenger RNAs for destruction.

Greg Hannon, Scott Lowe, and their collaborators used a well-studied gene in a well-studied organism--tumor suppressor p53 in mice (M. Hemann et al., "An epiallelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo," Nature Genetics, published online Feb. 3, 2003, www.nature.com). In mice with B lymphoma, they destroyed bone marrow, then reconstituted it from hematopoietic stem cells bearing any of several different shRNAs corresponding to parts of the p53 gene. Complete deletion of p53 is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies